Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Détails

ID Serval
serval:BIB_96BD38D42E6D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
Périodique
Antimicrobial agents and chemotherapy
Auteur⸱e⸱s
Glampedakis E. (co-premier), Coste A.T. (co-premier), Aruanno M., Bachmann D., Delarze E., Erard V., Lamoth F.
ISSN
1098-6596 (Electronic)
ISSN-L
0066-4804
Statut éditorial
Publié
Date de publication
12/2018
Peer-reviewed
Oui
Volume
62
Numéro
12
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Invasive fungal infections due to Aspergillus calidoustus with decreased azole susceptibility are emerging in the setting of azole prophylaxis and are associated with poor outcomes. We assessed the in vitro activity of antifungal drugs used alone or in combinations against A. calidoustus and found a synergistic effect between voriconazole and terbinafine at concentrations within the therapeutic range. An invertebrate Galleria mellonella model of A. calidoustus infection tended to support the potential benefit of this combination.
Mots-clé
Animals, Antifungal Agents/pharmacology, Antifungal Agents/therapeutic use, Aspergillosis/drug therapy, Aspergillus/drug effects, Aspergillus/isolation & purification, Disease Models, Animal, Drug Synergism, Drug Therapy, Combination, Humans, Microbial Sensitivity Tests, Moths, Terbinafine/therapeutic use, Voriconazole/therapeutic use, Aspergillus ustus, Galleria mellonella, Usti, amphotericin B, invasive fungal infections, synergism, terbinafine, voriconazole
Pubmed
Web of science
Création de la notice
30/10/2018 12:01
Dernière modification de la notice
25/02/2022 6:36
Données d'usage